AAV, EBS, RBL, RWR, IYG, AFG Are Seasonally Ripe To Go Down In the Next Five Weeks
September 15, 2016 / M2 PRESSWIRE / BUYINS.NET / www.buyins.net is monitoring the Seasonality of Advantage Oil & Gas Ltd. (NYSE:AAV), Emergent BioSolutions Inc. (NYSE:EBS), SPDR S&P Russia (NYSE:RBL), SPDR DJ Wilshire REIT ETF (NYSE:RWR), iShares Dow Jones U.S. Financial Services Index Fund (NYSE:IYG), American Financial Group Inc. (NYSE:AFG) and each have a high seasonal probability to go Down in the next weeks. By identifying stocks that are poised to go up or down based on seasonal tendencies, traders can increase their odds of making money. buyins.net is able to analyze over 20 years of data in less than 1 second for any stock in the market and determine if the stock has a long or short seasonal bias, how many trading days the move is expected to last, the probability of that move and the percentage move the stock is expected to make based on the seasonal bias. The technology used to generate these predictions is available for a low monthly fee at:
The following stocks are expected to go Down:
Symbol Company Expected Return Odds By The Following Date AAV Advantage Oil & Gas Ltd. -1.39% 90.00% (9 of 10) Friday, September 16th 2016 EBS Emergent BioSolutions Inc. -3.75% 100.00% (9 of 9) Monday, September 26th 2016 RBL SPDR S&P Russia -1.54% 66.67% (4 of 6) Friday, September 16th 2016 RWR SPDR DJ Wilshire REIT ETF -3.07% 85.71% (12 of 14) Monday, September 26th 2016 IYG iShares Dow Jones U.S. Financial Services Index Fund -3.33% 86.67% (13 of 15) Tuesday, September 27th 2016 AFG American Financial Group Inc. -2.79% 90.00% (18 of 20) Monday, September 26th 2016Advantage Oil & Gas Ltd. (NYSE:AAV) - Advantage Oil & Gas Ltd., together with its subsidiaries, acquires, exploits, develops, and produces oil and gas in the province of Alberta, Canada. The company produces and sells crude oil, natural gas, and natural gas liquids primarily through marketing companies. It principally focuses on the development and delineation of its Montney natural gas and liquids resource that consists of 137 net sections of land in Glacier, Alberta. The company was founded in 2001 and is headquartered in Calgary, Canada..
Emergent BioSolutions Inc. (NYSE:EBS) - Emergent BioSolutions, Inc., a specialty biopharmaceutical company, develops, manufactures, and sells specialized products to healthcare providers and governments in the United States and internationally. The company s Biodefense division markets BioThrax to treat anthrax disease; Anthrasil for the treatment of inhalational anthrax; BAT to treat botulinum disease; VIGIV to address the adverse events from smallpox vaccination; and RSDL for the removal or neutralization of chemical agents, T-2 toxins, and various pesticide-related chemicals from the skin. This division is also developing NuThrax, a next generation anthrax vaccine; UV-4B for dengue and influenza infections; GC-072, the compound in the EV-035 series of broad spectrum antibiotics for Burkholderia pseudomallei; VAX161C, a recombinant pandemic influenza vaccine; and PreviThrax, a recombinant protective antigen anthrax vaccine, as well as other products addressing public health threats and emerging infectious diseases. Its Aptevo division markets IXINITY to prevent bleeding episodes in people with hemophilia B; WinRho SDF to treat autoimmune platelet disorders and hemolytic disease of the newborn; HepaGam B for the post-exposure prophylactic treatment of hepatitis-B; and VARIZIG for the post-exposure prophylactic treatment of varicella zoster virus. This division s investigational stage product candidates include otlertuzumab, a protein therapeutic for Chronic Lymphocytic Leukemia; MOR209/ES414 for metastatic castration resistant prostate cancer under collaboration with MorphoSys AG; ES210, a protein therapeutic for inflammation-related indications; 5E3, a monoclonal antibody therapeutic for Alzheimer's disease; and other protein therapeutic product candidates primarily for the treatment of immuno-oncology. In addition, the company provides contract manufacturing services to third-party customers. Emergent BioSolutions, Inc. was founded in 1998 and is headquartered in Gaithersburg, Maryland..
SPDR S&P Russia (NYSE:RBL) - RBL.
SPDR DJ Wilshire REIT ETF (NYSE:RWR) - ST DJ WS REIT ETF.
iShares Dow Jones U.S. Financial Services Index Fund (NYSE:IYG) - ISHARE DJ FN SRV.
American Financial Group Inc. (NYSE:AFG) - American Financial Group, Inc., through its subsidiaries, provides property and casualty insurance products in the United States. It operates through four segments: Property and Casualty Insurance, Annuity, Run-Off Long-Term Care and Life, and Other. The company offers property and transportation insurance, which includes physical damage and liability coverage for buses, trucks and recreational vehicles, inland and ocean marine, agricultural-related products, and other property coverages; specialty casualty insurance, including primarily excess and surplus, general liability, executive liability, professional liability, umbrella and excess liability, and specialty coverage in targeted markets and customized programs for small to mid-sized businesses; and specialty financial insurance products comprising risk management insurance programs for leasing and financing institutions, surety and fidelity products, and trade credit insurance. It sells its property and casualty insurance products through independent insurance agents and brokers, as well as through employee agents. The company also provides traditional fixed and fixed-indexed annuities to the retail, financial institutions, and education markets; and workers' compensation insurance under the Summit brand name, as well as engages in the commercial real estate operations in Cincinnati, Whitefield, New Hampshire, Chesapeake Bay, Charleston, Palm Beach, greater Chicago, and Pittsburgh. American Financial Group, Inc. was founded in 1872 and is headquartered in Cincinnati, Ohio..
About BUYINS.NET
BUYINS.NET, http://www.buyins.net, monitors trading in all US stocks in real time and maintains massive databases of short sale and naked short sale time and sales data, short squeeze SqueezeTrigger prices, market-maker price movements, shareholder data, statistical data on earnings, sector correlation, seasonality, hedge fund trading strategies, comparable valuations. Reports include:
REGULATORY & COMPLIANCE NEWS Friction Factor - Market maker surveillance system tracking Level II market makers in all stocks to determine Price Friction and compliance with new "Fair Market Making Requirements" Naked Shorts (RegSho) - Tracks EVERY failure to deliver in all US stocks and tracks all Threshold Security Lists daily for which stocks have naked shorts that are not in compliance with Regulation SHO
INVESTMENTS & TRADING Earnings - Predicts probability, price move and length of move before and after all US stock earnings reports Seasonality - Predicts probability, price move and length of move based on exact time of year for all US stocks Group Correlation - Tracks sector rotation and stock correlation to its sector and predicts future moves in ALL sectors and industry groups SqueezeTrigger - Massive database that tracks EVERY short sale (not just total short interest) in all US stocks and calculates volume weighted price that a short squeeze will begin in each stock. Valuation - Tracks all known valuation models and applies them. GATS - Tracks and quantifies known trading strategies by backtesting, optimizing and running genetic algorithms and neural networks to ascertain best trading strategies. PatternScan - Automates tracking of every technical pattern and predicts next move in stocks. Insider - Tracks insiders trading records and determines trading performance. Trades by higher-level insiders are generally more predictive than trades by lower level insiders Events - Tracks patterns directly correlated to specific events.
SqueezeTrigger is a registered trademark, Reg. No. 3,120,641
DISCLAIMER:
BUYINS.NET is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell any securities. [symbol] has not approved the statements made in this release. Please read our report and visit our web site, http://www.buyins.net, for complete risks and disclosures.
Contact: BUYINS.NET Thomas Ronk 800-715-9999 tom@buyins.net http://www.buyins.net